Roche Opens Innovation Center Boston to Expand Cardiovascular, Renal and Metabolism Research Roche (SIX: RO, ROP; OTCQX: RHHBY) has officially opened the Roche Genentech Innovation Center Boston, marking a significant expansion of the company’s research and development presence in the…
AbbVie Presents New VRAYLAR Data Highlighting Real-World Outcomes in Depression and Bipolar I Disorder AbbVie (NYSE: ABBV) has presented new data for VRAYLAR® (cariprazine) at Psych Congress 2026 in New Orleans, Louisiana, highlighting findings from prospective real-world observational studies in…
Lilly to Present New Cardiometabolic Data on Foundayo, Retatrutide and EloraTZP at EASD 2026 Eli Lilly and Company (NYSE: LLY), the manufacturer of Zepbound® (tirzepatide), Mounjaro® (tirzepatide) and Foundayo® (orforglipron), is set to present a broad range of new data…
MaaT Pharma Reports CHMP Maintains Negative Opinion on MaaT013 for Acute Graft-versus-Host Disease MaaT Pharma (Euronext: MAAT), a clinical-stage biotechnology company developing Microbiome Ecosystem Therapies™ (MET) designed to modulate the immune system and improve outcomes for patients with cancer, announced…
Paradromics Connexus BCI Enables First Participant to Communicate in Real Time Using Neural Signals Paradromics Inc., a neurotechnology company developing a high-data-rate brain-computer interface (BCI) platform aimed at restoring and enhancing human capabilities, has announced a major clinical milestone involving…
Lightcast Appoints Sarah Taylor, PhD, as Vice President of Science to Advance Envisia Single-Cell Analysis Platform Lightcast, a life science tools company focused on functional single-cell analysis, has appointed Sarah Taylor, PhD, as Vice President of Science, effective immediately. Taylor…
Family Heart Foundation Study Shows Machine Learning Model Can Help Identify ASCVD Patients at Higher Risk of Elevated Lp(a) The Family Heart Foundation, a leading research, education and advocacy organization focused on cardiovascular health, has announced the publication of a…
Roche Receives FDA Priority Review for Enspryng in MOGAD Following Positive Phase 3 Results Roche announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) seeking approval of Enspryng® (satralizumab)…
One Biosciences and Institut Curie Secure €3.3 Million France 2030 Funding to Advance Single-Cell Diagnostics for Triple-Negative Breast Cancer One Biosciences, a techbio company spun out of Institut Curie and focused on developing clinical-grade single-cell tumor profiling technologies, and Institut…
Yarrow Bioscience Launches Underwritten Public Offering to Support Autoimmune Thyroid Disease Pipeline Yarrow Bioscience, Inc., a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, has announced the commencement of an underwritten public offering of its securities.…
Mobile Heartbeat Expands Banyan Platform with Private 5G Support for Healthcare Communications Mobile Heartbeat, a provider of clinical communication and collaboration solutions, has announced that its Banyan platform now supports private 5G networks, expanding the connectivity options available to healthcare…
BioLab Holdings Expands Placental Membrane Portfolio With New Membrane Wrap Amniotic Hydro BioLab Holdings, Inc., a Phoenix-based medical technology company focused on tissue restoration, has expanded its portfolio of placental membrane products with the addition of Membrane Wrap™ Amniotic Hydro.…